Skip to main content
Top
Gepubliceerd in: Journal of Autism and Developmental Disorders 6/2008

01-07-2008 | Original Paper

Intestinal Permeability and Glucagon-like peptide-2 in Children with Autism: A Controlled Pilot Study

Auteurs: Marli A. Robertson, David L. Sigalet, Jens J. Holst, Jon B. Meddings, Julie Wood, Keith A. Sharkey

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 6/2008

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

We measured small intestinal permeability using a lactulose:mannitol sugar permeability test in a group of children with autism, with current or previous gastrointestinal complaints. Secondly, we examined whether children with autism had an abnormal glucagon-like peptide-2 (GLP-2) response to feeding. Results were compared with sibling controls and children without developmental disabilities. We enrolled 14 children with autism, 7 developmentally normal siblings of these children and 8 healthy, developmentally normal, unrelated children. Our study did not detect differences in these measures of gastrointestinal function in a group of children with autism.
Literatuur
go back to reference Ahearn, W. H., Castine, T., Nault, K., & Green, G. (2001). An assessment of food acceptance in children with autism or pervasive developmental disorder-not otherwise specified. Journal of Autism and Developmental Disorders, 31(5), 505–511.PubMedCrossRef Ahearn, W. H., Castine, T., Nault, K., & Green, G. (2001). An assessment of food acceptance in children with autism or pervasive developmental disorder-not otherwise specified. Journal of Autism and Developmental Disorders, 31(5), 505–511.PubMedCrossRef
go back to reference Blaxill, M. F. (2004). What’s going on? The question of time trends in autism. Public Health Reports, 119(6), 536–551.PubMedCrossRef Blaxill, M. F. (2004). What’s going on? The question of time trends in autism. Public Health Reports, 119(6), 536–551.PubMedCrossRef
go back to reference Breslin, N. P., Nash, C., Hilsden, R. J., Hershfield, N. B., Price, L. M., Meddings, J. B., & Sutherland, L. R. (2001). Intestinal permeability is increased in a proportion of spouses of patients with Crohn’s disease. The American Journal of Gastroenterology, 96(10), 2934–2938.PubMedCrossRef Breslin, N. P., Nash, C., Hilsden, R. J., Hershfield, N. B., Price, L. M., Meddings, J. B., & Sutherland, L. R. (2001). Intestinal permeability is increased in a proportion of spouses of patients with Crohn’s disease. The American Journal of Gastroenterology, 96(10), 2934–2938.PubMedCrossRef
go back to reference Chakrabarti, S., & Fombonne, E. (2005). Pervasive developmental disorders in preschool children: confirmation of high prevalence. The American Journal of Psychiatry, 162(6), 1133–1141.PubMedCrossRef Chakrabarti, S., & Fombonne, E. (2005). Pervasive developmental disorders in preschool children: confirmation of high prevalence. The American Journal of Psychiatry, 162(6), 1133–1141.PubMedCrossRef
go back to reference Charman, T. (2002). The prevalence of autism spectrum disorders. Recent evidence and future challenges. European Child & Adolescent Psychiatry, 11(6), 249–256.CrossRef Charman, T. (2002). The prevalence of autism spectrum disorders. Recent evidence and future challenges. European Child & Adolescent Psychiatry, 11(6), 249–256.CrossRef
go back to reference D’Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E., & Giardini, O. (1996). Abnormal intestinal permeability in children with autism. Acta Paediatrica, 85(9), 1076–1079.PubMedCrossRef D’Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E., & Giardini, O. (1996). Abnormal intestinal permeability in children with autism. Acta Paediatrica, 85(9), 1076–1079.PubMedCrossRef
go back to reference Drucker, D. J. (2005). Biologic actions and therapeutic potential of the proglucagon-derived peptides. Nature Clinical Practice Endocrinology & Metabolism, 1(1), 22–31.CrossRef Drucker, D. J. (2005). Biologic actions and therapeutic potential of the proglucagon-derived peptides. Nature Clinical Practice Endocrinology & Metabolism, 1(1), 22–31.CrossRef
go back to reference Erickson, C. A., Stigler, K. A., Corkins, M. R., Posey, D. J., Fitzgrald, J. F., & McDougle, C. J. (2005). Gastrointestinal factors in autistic disorder: A critical review. Journal of Autism and Developmental Disorders, 35(6), 713–727.PubMedCrossRef Erickson, C. A., Stigler, K. A., Corkins, M. R., Posey, D. J., Fitzgrald, J. F., & McDougle, C. J. (2005). Gastrointestinal factors in autistic disorder: A critical review. Journal of Autism and Developmental Disorders, 35(6), 713–727.PubMedCrossRef
go back to reference Estall, J. L., & Drucker, D. J. (2006). Glucagon-like Peptide-2. Annual Review of Nutrition, 26, 391–411.PubMedCrossRef Estall, J. L., & Drucker, D. J. (2006). Glucagon-like Peptide-2. Annual Review of Nutrition, 26, 391–411.PubMedCrossRef
go back to reference Field, D., Garland, M., & Williams, K. (2003). Correlates of specific childhood feeding problems. Journal of Paediatrics and Child Health, 39(4), 299–304.PubMedCrossRef Field, D., Garland, M., & Williams, K. (2003). Correlates of specific childhood feeding problems. Journal of Paediatrics and Child Health, 39(4), 299–304.PubMedCrossRef
go back to reference Furlano, R. I., Anthony, A., Day, R., Brown, A., & McGarvey, L. et al. (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. The Journal of Pediatrics, 138(3), 366–372.PubMedCrossRef Furlano, R. I., Anthony, A., Day, R., Brown, A., & McGarvey, L. et al. (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. The Journal of Pediatrics, 138(3), 366–372.PubMedCrossRef
go back to reference Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., & Tildon, J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder. The Journal of Pediatrics 135(5), 559–563.PubMedCrossRef Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., & Tildon, J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder. The Journal of Pediatrics 135(5), 559–563.PubMedCrossRef
go back to reference Horvath, K., Zielke, R. H., Collins, R. M., Rabsztyn, A., Medeiros, L. A., & Perman, J. (2000). Secretin improves intestinal permeability in autistic children. Journal of Pediatric Gastroenterology Nutrition, 31, S31. Horvath, K., Zielke, R. H., Collins, R. M., Rabsztyn, A., Medeiros, L. A., & Perman, J. (2000). Secretin improves intestinal permeability in autistic children. Journal of Pediatric Gastroenterology Nutrition, 31, S31.
go back to reference James, M. W., & Scott, B. B. (2000). Endomysial antibody in the diagnosis and management of coeliac disease. Postgraduate Medical Journal, 76(898), 466–468.PubMedCrossRef James, M. W., & Scott, B. B. (2000). Endomysial antibody in the diagnosis and management of coeliac disease. Postgraduate Medical Journal, 76(898), 466–468.PubMedCrossRef
go back to reference Kuddo, T., & Nelson, K. B. (2003). How common are gastrointestinal disorders in children. Current Opinion in Pediatrics, 15, 339–343.PubMedCrossRef Kuddo, T., & Nelson, K. B. (2003). How common are gastrointestinal disorders in children. Current Opinion in Pediatrics, 15, 339–343.PubMedCrossRef
go back to reference Liu, Z., & Neu, J. (2005). Tight junctions, leaky intestines, and pediatric diseases. Acta Pediatrica., 94(4), 386–393.CrossRef Liu, Z., & Neu, J. (2005). Tight junctions, leaky intestines, and pediatric diseases. Acta Pediatrica., 94(4), 386–393.CrossRef
go back to reference Marsilio, R., D’Antiga, L., Zancan, L., Dussini, N., & Zacchello, F. (1998) Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clinical Chemistry, 44, 1685–1691.PubMed Marsilio, R., D’Antiga, L., Zancan, L., Dussini, N., & Zacchello, F. (1998) Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clinical Chemistry, 44, 1685–1691.PubMed
go back to reference Martin, G. R., Wallace, L. E., & Sigalet, D. L. (2004). Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. American Journal of Physiology. Gastrointestinal and Liver Physiology, 286(6), G964–G972.PubMedCrossRef Martin, G. R., Wallace, L. E., & Sigalet, D. L. (2004). Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. American Journal of Physiology. Gastrointestinal and Liver Physiology, 286(6), G964–G972.PubMedCrossRef
go back to reference Martin, G. R., Beck, P. L., & Sigalet, D. L. (2006). Gut hormones, and short bowel syndrome: The enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World Journal of Gastroenterology, 12(26), 4117–4129.PubMed Martin, G. R., Beck, P. L., & Sigalet, D. L. (2006). Gut hormones, and short bowel syndrome: The enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World Journal of Gastroenterology, 12(26), 4117–4129.PubMed
go back to reference May, G. R., Sutherland, L. R., & Meddings, J. B. (1993). Is small intestinal permeability really increased in relatives of patients with Crohn’s disease? Gastroenterology, 104(6), 1627–1632.PubMed May, G. R., Sutherland, L. R., & Meddings, J. B. (1993). Is small intestinal permeability really increased in relatives of patients with Crohn’s disease? Gastroenterology, 104(6), 1627–1632.PubMed
go back to reference Meddings, J. B., Sutherland, L. R., & May, G. R. (1994). Intestinal permeability in patients with Crohn’s disease. Gut, 35(11), 1675–1676.PubMedCrossRef Meddings, J. B., Sutherland, L. R., & May, G. R. (1994). Intestinal permeability in patients with Crohn’s disease. Gut, 35(11), 1675–1676.PubMedCrossRef
go back to reference Meddings, J. B. (1997). Review article: Intestinal permeability in Crohn’s disease. Alimentary Pharmacology & Therapeutics, 11(Suppl 3), 47–53 (discussion 53–56). Meddings, J. B. (1997). Review article: Intestinal permeability in Crohn’s disease. Alimentary Pharmacology & Therapeutics, 11(Suppl 3), 47–53 (discussion 53–56).
go back to reference Molloy, C. A., & Manning-Courtney, P (2003). Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism, 7(2), 165–171.PubMedCrossRef Molloy, C. A., & Manning-Courtney, P (2003). Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism, 7(2), 165–171.PubMedCrossRef
go back to reference Murphy, M. S., Eastham, E. J., Nelson, R., Pearson, A. D. J., & Laker, M. F. (1989) Intestinal permeability in Crohn’s Disease. Archives of Disease in Childhood, 64, 321–325.PubMedCrossRef Murphy, M. S., Eastham, E. J., Nelson, R., Pearson, A. D. J., & Laker, M. F. (1989) Intestinal permeability in Crohn’s Disease. Archives of Disease in Childhood, 64, 321–325.PubMedCrossRef
go back to reference Raiten, D. J., & Massaro, T. (1986). Perspectives on the nutritional ecology of autistic children. Journal of Autism and Developmental Disorders, 16(2), 133–143.PubMedCrossRef Raiten, D. J., & Massaro, T. (1986). Perspectives on the nutritional ecology of autistic children. Journal of Autism and Developmental Disorders, 16(2), 133–143.PubMedCrossRef
go back to reference Rice, C., (2007) Prevalence of autism spectrum disorders–Autism and developmental disabilities monitoring network, 14 Sites, United States, 2002. MMWR Surveillance Summaries, 56 (SS01); 12–28. Rice, C., (2007) Prevalence of autism spectrum disorders–Autism and developmental disabilities monitoring network, 14 Sites, United States, 2002. MMWR Surveillance Summaries, 56 (SS01); 12–28.
go back to reference Shattock, P., & Whiteley, P. (2002). Biochemical aspects in autism spectrum disorders: Updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opinion on Therapeutic Targets, 6(2), 175–183.PubMedCrossRef Shattock, P., & Whiteley, P. (2002). Biochemical aspects in autism spectrum disorders: Updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opinion on Therapeutic Targets, 6(2), 175–183.PubMedCrossRef
go back to reference Sigalet, D. L., Martin, G., Meddings, J., Hartman, B., & Holst, J. J. (2004). GLP-2 levels in infants with intestinal dysfunction. Pediatric Research, 56(3), 371–376.PubMedCrossRef Sigalet, D. L., Martin, G., Meddings, J., Hartman, B., & Holst, J. J. (2004). GLP-2 levels in infants with intestinal dysfunction. Pediatric Research, 56(3), 371–376.PubMedCrossRef
go back to reference Sigalet, D. L., Bawazir, O., Martin, G. R., Wallace, L. E., Zaharko, G., Miller, A., & Zubaidi, A. (2006). Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum. Digestive Diseases and Sciences, 51(9), 1557–1566.PubMedCrossRef Sigalet, D. L., Bawazir, O., Martin, G. R., Wallace, L. E., Zaharko, G., Miller, A., & Zubaidi, A. (2006). Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum. Digestive Diseases and Sciences, 51(9), 1557–1566.PubMedCrossRef
go back to reference Topstad, D., Martin, G., & Sigalet, D. (2001). Systemic GLP-2 levels do not limit adaptation after distal intestinal resection. Journal of Pediatric Surgery, 36(5), 750–754.PubMedCrossRef Topstad, D., Martin, G., & Sigalet, D. (2001). Systemic GLP-2 levels do not limit adaptation after distal intestinal resection. Journal of Pediatric Surgery, 36(5), 750–754.PubMedCrossRef
go back to reference Torrente, F., Ashwood, P., Day, R., Machado, N., & Furlano, R. I. et al. (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Molecular Psychiatry, 7(4), 375–382.PubMedCrossRef Torrente, F., Ashwood, P., Day, R., Machado, N., & Furlano, R. I. et al. (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Molecular Psychiatry, 7(4), 375–382.PubMedCrossRef
go back to reference Valicenti-McDermott, M., McVicar, A., Rapin, I., Wershil, B. K., Cohen, H., & Shinnar, S., (2006). Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. Journal of Developmental and Behavioral Pediatrics, 27, S128–S136.PubMedCrossRef Valicenti-McDermott, M., McVicar, A., Rapin, I., Wershil, B. K., Cohen, H., & Shinnar, S., (2006). Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. Journal of Developmental and Behavioral Pediatrics, 27, S128–S136.PubMedCrossRef
go back to reference Van Elburg, R. M., Uil, J. J., Mulder, C. J., & Heymans, H. S. (1993). Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut, 34, 354–357.PubMedCrossRef Van Elburg, R. M., Uil, J. J., Mulder, C. J., & Heymans, H. S. (1993). Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut, 34, 354–357.PubMedCrossRef
go back to reference Van Elburg, R. M., Uil, J. J., Kokke, F. T., Mulder, A. M., van der Broek, W. G., Mulder, C. J., & Heymans, H. S. (1995). Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. Journal of Pediatric Gastroenterology Nutrition, 20, 184–188.CrossRef Van Elburg, R. M., Uil, J. J., Kokke, F. T., Mulder, A. M., van der Broek, W. G., Mulder, C. J., & Heymans, H. S. (1995). Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. Journal of Pediatric Gastroenterology Nutrition, 20, 184–188.CrossRef
go back to reference Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., & Casson, D. M., et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351(9103), 637–641.PubMedCrossRef Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., & Casson, D. M., et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351(9103), 637–641.PubMedCrossRef
go back to reference Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., & Montgomery, S. M. et al. (2000). Enterocolitis in children with developmental disorders. The American Journal of Gastroenterology, 95(9), 2285–2295.PubMedCrossRef Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., & Montgomery, S. M. et al. (2000). Enterocolitis in children with developmental disorders. The American Journal of Gastroenterology, 95(9), 2285–2295.PubMedCrossRef
go back to reference Wakefield, A. J., Puleston, J. M., Montgomery, S. M., Anthony, A., & O’Leary, J. J. et al. (2002). Review article: The concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacology & Therapeutics, 16(4), 663–674.CrossRef Wakefield, A. J., Puleston, J. M., Montgomery, S. M., Anthony, A., & O’Leary, J. J. et al. (2002). Review article: The concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacology & Therapeutics, 16(4), 663–674.CrossRef
go back to reference Wakefield A. J., Ashwood P., Limb K., & Anthony, A. (2005). The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. European Journal of Gastroenterology & Hepatology, 17(8), 827–836.CrossRef Wakefield A. J., Ashwood P., Limb K., & Anthony, A. (2005). The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. European Journal of Gastroenterology & Hepatology, 17(8), 827–836.CrossRef
Metagegevens
Titel
Intestinal Permeability and Glucagon-like peptide-2 in Children with Autism: A Controlled Pilot Study
Auteurs
Marli A. Robertson
David L. Sigalet
Jens J. Holst
Jon B. Meddings
Julie Wood
Keith A. Sharkey
Publicatiedatum
01-07-2008
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 6/2008
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-007-0482-1

Andere artikelen Uitgave 6/2008

Journal of Autism and Developmental Disorders 6/2008 Naar de uitgave